Toronto Dominion Bank
MDGL icon

Toronto Dominion Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

Toronto Dominion Bank’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.4M Buy
181,432
+50,972
+39% +$26.1M 0.11% 168
2026
Q1 		$68.3M Buy
+130,460
New +$62.3M 0.1% 182
2022
Q1 		– Sell
-10,744
Closed -$910K – 1754
2021
Q4 		$910K Buy
+10,744
New +$883K ﹤0.01% 1066

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Toronto Dominion Bank's MDGL Position: Q2 2026 in Review

Toronto Dominion Bank increased its Madrigal Pharmaceuticals (MDGL) stake by 39% in Q2 2026, buying an estimated $26.1M and bringing the position to 181,432 shares worth $97.4M. The position accounts for 0.11% of the portfolio, ranked #168.

Toronto Dominion Bank first reported a position in MDGL in Q4 2021 and has held it in 3 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Toronto Dominion Bank held 181,432 shares of Madrigal Pharmaceuticals worth $97.4M as of Q2 2026.
  • Toronto Dominion Bank bought 50,972 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $26.1M.
  • Madrigal Pharmaceuticals made up 0.11% of Toronto Dominion Bank's portfolio in Q2 2026, its #168 holding.
  • Toronto Dominion Bank first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 3 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.